6 patent families
• Portfolio of 62 granted patents with 8
patent applications under examination
Covers
neurodegenerative diseases
specifically Amyotrophic Lateral
Sclerosis, Alzheimer’s Disease,
Parkinson’s Disease & Huntington’s
Disease
Long Runway
Key patent granted in the US
(US 9,790,176) for “Compounds
For The Treatment of mTOR Pathway
Related Diseases”.
• Projected expiry for these patents
is August 2033.
clawing back the lost ground ,,, value lost for the FDA query is circa $38m , so making up ground swiftly already today NZT
Ann: Neurizon to Present Latest Results and Key Updates, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.92M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $101.5K | 583.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29920 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 15.58pm 29/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |